Mal-PEG2-Val-Cit-amido-PAB-OH
≥95%
- Product Code: 106289
CAS:
2055041-38-6
Molecular Weight: | 618.68 g./mol | Molecular Formula: | C₂₉H₄₂N₆O₉ |
---|---|---|---|
EC Number: | MDL Number: | ||
Melting Point: | Boiling Point: | ||
Density: | Storage Condition: | -20°C, away from light, dry, sealed |
Product Description:
Used in the development of antibody-drug conjugates (ADCs), this compound serves as a linker to connect cytotoxic drugs to antibodies. It enables targeted delivery of therapeutic agents to specific cells, minimizing damage to healthy tissues. The Val-Cit sequence is cleavable by cathepsin B, an enzyme found in lysosomes, ensuring controlled drug release. The PAB (para-aminobenzyl) group enhances stability in circulation, while the PEG2 spacer improves solubility and reduces aggregation. This makes it a critical component in cancer therapy, enhancing the efficacy and safety of ADCs.
Sizes / Availability / Pricing:
Size (g) | Availability | Price | Quantity |
---|---|---|---|
0.050 | 10-20 days | ฿30,600.00 |
+
-
|
Mal-PEG2-Val-Cit-amido-PAB-OH
Used in the development of antibody-drug conjugates (ADCs), this compound serves as a linker to connect cytotoxic drugs to antibodies. It enables targeted delivery of therapeutic agents to specific cells, minimizing damage to healthy tissues. The Val-Cit sequence is cleavable by cathepsin B, an enzyme found in lysosomes, ensuring controlled drug release. The PAB (para-aminobenzyl) group enhances stability in circulation, while the PEG2 spacer improves solubility and reduces aggregation. This makes it a critical component in cancer therapy, enhancing the efficacy and safety of ADCs.
Mechanism | - |
Appearance | - |
Longevity | - |
Strength | - |
Storage | - |
Shelf Life | - |
Allergen(s) | - |
Dosage (Range) | - |
Recommended Dosage | - |
Dosage (Per Day) | - |
Recommended Dosage (Per Day) | - |
Mix Method | - |
Heat Resistance | - |
Stable in pH range | - |
Solubility | - |
Product Types | - |
INCI | - |
Cart
No products
Subtotal:
฿0.00
฿0.00
Total :